Co-designing VR for Teenage Oncology

  • Research type

    Research Study

  • Full title

    Co-designing a Novel Virtual Reality Experience with Teenage and Young Adults with Cancer for use in the Oncology Pathway

  • IRAS ID

    312897

  • Contact name

    Kirsten Cater

  • Contact email

    kirsten.cater@bristol.ac.uk

  • Sponsor organisation

    University of Bristol

  • Clinicaltrials.gov Identifier

    Id nr.: 1868827, Sponsor reference Number

  • Duration of Study in the UK

    1 years, 4 months, 1 days

  • Research summary

    This study aims to co-design a virtual reality (VR) experience for teenagers and young adults with cancer. Young people (16-24) with cancer from the teenage cancer unit in Bristol (UHBW NHS trust) will be invited to engage in a series of co-design workshops to iteratively design and develop a VR experience for use in the oncology pathway. The young people will help identify an area of the pathway that may benefit from a virtual reality application and then work alongside researchers from the University of Bristol to co-design this application.

    VR has shown great potential across healthcare with particular success in surgical training, psychotherapy, rehabilitation and as a distraction tool. More recently, VR has been used across different parts of the cancer pathway. This has included using VR to prepare children for scans and as a distraction tool during chemotherapy and painful procedures. There is currently very little research into the use of VR in teenage and young adult cancer. This study will bring young people with cancer and researchers from the University of Bristol together to conceptualise and co-design a novel VR app for use in teenage and young adult cancer. This study will also advance our understanding of the current challenges and opportunities for VR technology in oncology and highlight practical considerations necessary for the effective development and deployment of VR technology in the NHS.

  • REC name

    London - Queen Square Research Ethics Committee

  • REC reference

    23/PR/0365

  • Date of REC Opinion

    24 May 2023

  • REC opinion

    Further Information Favourable Opinion